| Publications |
(Currently 512486 Items)
|
 |
| Partners |
|
|
|
| BIOTECHNOLOGY / Total: 9100 |
PREVIOUS | 5
| 6
| 7
| 8
| 9
| 10
| 11
| 12
| 13
| 14
| 15
| 16
| 17
|
NEXT 
|
| Title |
Date |
Price |
|
The Praecis Pharmaceuticals Incorporated Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products... |
Jan, 2007 |
€375 |
|
The Prana Biotechnology Ltd Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
Introduction:This brief gauges the prospects for change in card issuer business models in the UK and Europe. With previously successful monoline issuers withdrawing from the European theatre, this brief... |
Apr, 2002 |
€1 814 |
|
The Pressure BioSciences Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Mar, 2006 |
€375 |
|
The Procter & Gamble Company Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The Procyon Corp Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Progen Industries Limited Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Oct, 2006 |
€375 |
|
The Progenics Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The Pro-Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The Protalex Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Protein Design Labs Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The Protein Polymer Technologies Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products... |
Oct, 2006 |
€375 |
|
The Protherics PLC Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Mar, 2006 |
€375 |
|
Introduction:The Vaccine sector is entering a new era, with the recent and forthcoming launch of new, innovative high value products. These will shift the market from being led by inclusion or otherwise... |
Oct, 2003 |
€8 132 |
|
The Provectus Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The Psivida Ltd Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Psychemedics Corp Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Oct, 2006 |
€375 |
|
The Qiagen N.V Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Mar, 2006 |
€375 |
|
The QLT Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and... |
Jan, 2007 |
€375 |
|
The Questcor Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
|
|
|
